출판 : MarketsandMarkets（마켓츠앤드마켓츠）출판년월 : 2022년04월
ATP 측정 시장 : 제품[소모품(키트, 시약, 마이크로 플레이트), 기기(루미노미터, 분광광도계)], 용도(오염, 질병 검사, 창약), 최종 사용자(병원, 의약품, 식품 검사) – 2027년까지 세계 예측
ATP Assays Market by Product (Consumables (Kits, Reagent, Microplate), Instrument (Luminometer, Spectrophotometers)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, Food Testing) – Global Forecast to 2027
| 페이지수 | 222 |
| 도표수 | 204 |
| 구성 | 영문조사보고서 |
| 가격 |
The global ATP assays market is projected to reach USD 412 million by 2027 from USD 276 million in 2022, at a CAGR of 8.4%. The growth of this market can largely be attributed to the increasing food safety concerns, growing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology R&D, increasing prevalence of cancer and other chronic and infectious diseases, and the shift from culture-based tests to rapid tests. However, the high cost of instruments and inability to differentiate between extracellular and intracellular ATP are expected to restrain the growth of this market to a certain extent.
전 세계 ATP 분석 시장은 CAGR 8.4%로 2022년 2억 7,600만 달러에서 2027년 4억 1,200만 달러에 이를 것으로 예상됩니다. 이 시장의 성장은 식품 안전에 대한 관심 증가, 제약 및 생명 공학 회사의 ATP 분석에 대한 수요 증가, 제약 및 생명 공학 R&D에 대한 투자 증가, 암 및 기타 만성 및 전염병의 유병률 증가, 신속한 테스트에 대한 문화 기반 테스트. 그러나 기기의 높은 비용과 세포외 ATP와 세포내 ATP를 구별할 수 없는 능력으로 인해 이 시장의 성장이 어느 정도 억제될 것으로 예상됩니다.
보고서 주요 목차
- 요약
- 프리미엄 인사이트
- 시장 개관
- ATP 제품별, 분석 시장
- ATP 용도별, 분석 시장
- ATP 최종 사용자별, 분석 시장
- ATP 지역별, 분석 시장
- 경쟁 구도
“The consumables and accessories segment accounted for the largest share of the ATP assays, based on product in 2021.”
Based on products, the ATP assays market is segmented into consumables & accessories and instruments. The large share of consumables & accessories segment is attributed to the extensive usage of ATP assays in research institutes to measure cell viability, increase in drug discovery due to a surge in chronic diseases which requires tumor testing and cell proliferation (in cancer), and the repeated purchase of consumables by pharmaceutical and biotechnology companies.
“Contamination Testing accounted for the largest share of the market.”
The ATP assays market is segmented into contamination testing, disease testing, and drug discovery & development. The large share of the contamination testing segment can be attributed to the rising regulatory stringency of pharmaceutical and food & beverage companies for non-contaminated production, an increase in drug discovery post COVID-19, and the need for cleaning and disinfection of environmental surfaces in hospitals.
“Pharmaceutical & Biotechnology companies hold the largest share in the market, by end user”
The large share of Pharmaceutical & Biotechnology companies in the end user segment can be attributed to the presence of a large number of pharmaceutical players with growing investments in this market, growing regulatory approvals for cell culture-based vaccines which require the use of ATP assays in contamination testing, commercial expansion of various pharmaceutical companies, the increasing demand for cell and gene therapies for chronic diseases, significant R&D in pharmaceutical & biopharmaceutical companies, increasing production of COVID-19 drugs, increasing adoption of cell-based assays for drug development, and the ease of use of ATP assays in contamination testing.
“The APAC to witness the highest growth during the forecast period.”
Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2022–2027. This regional market is expected to register the highest growth rate during the forecast period as several APAC countries are witnessing a growing number of proteomics, genomics, and stem cell research activities. The increasing incidence of chronic & infectious diseases, increasing drug discovery & development studies, favorable regulatory guidelines, the growing focus of global market players on emerging Asian economies, increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and research infrastructure modernization are some of the key factors driving the market for ATP assays.
Break of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%
Key players in the ATP Assays Market
The prominent players in the ATP assays market are Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Merck KGaA (Germany), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Abcam plc (UK), Lonza Group (Switzerland), NEOGEN Corporation (US), 3M (US), Danaher Corporation (US), PromoCell GmbH (Germany), Geno Technology, Inc. (US), Abnova Corporation (Taiwan), AAT Bioquest (US), BioThema AB (Sweden), Elabscience Biotechnology Inc. (US), MBL International Corporation (US), Biotium (US), Creative Bioarray (US), Canvax Biotech S.L. (Spain), Ruhof Corporation (US), Charm Sciences, Inc. (US), Bio Shield Tech LLC (US), Cayman Chemical (US), and Cell Signaling Technology (US).
Research Coverage:
The report analyzes the ATP assays market and aims at estimating the market size and future growth potential of this market based on various segments such as product, application, end user, and region. The report also includes a product portfolio matrix of various ATP assays products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the ATP assays market. The report analyzes this market by product, by application, and by end user.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global ATP assays market
• Market Development: Comprehensive information on the lucrative emerging markets by product, application, and end user
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global ATP assays market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global ATP assays market.
목차
TABLE OF CONTENTS
1 INTRODUCTION (Page No. – 24)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKET SEGMENTATION
FIGURE 1 ATP ASSAYS MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. – 29)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS
2.2 MARKET SIZE ESTIMATION
FIGURE 7 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 10 CAGR PROJECTIONS
FIGURE 11 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 12 DATA TRIANGULATION METHODOLOGY
2.4 MARKET RANKING ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: ATP ASSAYS MARKET
3 EXECUTIVE SUMMARY (Page No. – 42)
FIGURE 13 ATP ASSAYS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 14 ATP ASSAYS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 15 ATP ASSAYS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE ATP ASSAYS MARKET
4 PREMIUM INSIGHTS (Page No. – 46)
4.1 ATP ASSAYS MARKET OVERVIEW
FIGURE 17 INCREASING FOOD SAFETY CONCERNS TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: ATP ASSAYS MARKET, BY END USER AND COUNTRY (2021)
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2021
4.3 ATP ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 CHINA TO REGISTER THE HIGHEST GROWTH IN THE ATP ASSAYS MARKET DURING THE FORECAST PERIOD
4.4 ATP ASSAYS MARKET, BY REGION (2020–2027)
FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE ATP ASSAYS MARKET IN 2027
4.5 ATP ASSAYS MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. – 50)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 3 ATP ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Increasing food safety concerns
5.2.1.2 Growing demand for ATP assays in pharmaceutical & biotechnology companies
5.2.1.3 Rising investments in pharmaceutical & biotechnology R&D
FIGURE 22 GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026 (USD BILLION)
5.2.1.4 Increasing prevalence of cancer
FIGURE 23 GLOBAL CANCER INCIDENCE, 2018 VS. 2030 (MILLION)
5.2.1.5 Shift from culture-based tests to rapid-tests
5.2.1.6 Rising incidence and prevalence of chronic and infectious diseases
5.2.2 MARKET RESTRAINTS
5.2.2.1 High cost of instruments
5.2.2.2 Inability to differentiate between extracellular and intracellular ATP
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Technological enhancements in ATP assay probes
5.2.3.2 Growth prospects in emerging markets
5.2.4 MARKET CHALLENGES
5.2.4.1 Survival of small players and new entrants
5.3 INDUSTRY TRENDS
5.3.1 INCREASING REGULATIONS FOR FOOD BUSINESSES
5.3.2 ADOPTION OF ATP TESTING FOR MONITORING ENVIRONMENTAL CONTAMINATION CAUSED BY SARS-COV-2
5.4 IMPACT OF COVID-19 ON THE ATP ASSAYS MARKET
5.5 PATENT ANALYSIS
5.5.1 PATENT PUBLICATION TRENDS FOR ATP ASSAYS
FIGURE 24 PATENT PUBLICATION TRENDS (JANUARY 2011–FEBRUARY 2022)
5.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 25 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTES) FOR ATP ASSAY PATENTS (JANUARY 2011–FEBRUARY 2022)
FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR ATP ASSAYS (JANUARY 2011–FEBRUARY 2022)
5.5.3 LIST OF PATENTS/PATENT APPLICATIONS IN THE ATP ASSAYS MARKET
5.6 VALUE CHAIN ANALYSIS
FIGURE 27 ATP ASSAYS MARKET: VALUE CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
FIGURE 28 ATP ASSAYS MARKET: ECOSYSTEM ANALYSIS
5.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 ATP ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 PRICING ANALYSIS
5.9.1 REGIONAL PRICING ANALYSIS OF ATP ASSAYS, 2021 (USD)
6 ATP ASSAYS MARKET, BY PRODUCT (Page No. – 70)
6.1 INTRODUCTION
TABLE 5 ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 CONSUMABLES & ACCESSORIES
TABLE 6 KEY ATP CONSUMABLES & ACCESSORIES AVAILABLE IN THE MARKET
TABLE 7 ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 8 ATP CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1 REAGENTS & KITS
6.2.1.1 Reagents play a significant role in the identification and detection of cells in cancer research
TABLE 9 REAGENTS & KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2 MICROPLATES
6.2.2.1 Extensive use of microplates for assay development is driving their adoption
TABLE 10 MICROPLATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3 OTHER CONSUMABLES & ACCESSORIES
TABLE 11 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 INSTRUMENTS
TABLE 12 ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 13 ATP INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 14 KEY ATP INSTRUMENTS AVAILABLE IN THE MARKET
6.3.1 LUMINOMETERS
6.3.1.1 Luminometers are comparatively low-priced and, therefore, widely adopted
TABLE 15 LUMINOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.2 SPECTROPHOTOMETERS
6.3.2.1 Spectrophotometers are costlier than luminometers and, therefore, less preferred by end users in the ATP assays market
TABLE 16 SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 ATP ASSAYS MARKET, BY APPLICATION (Page No. – 81)
7.1 INTRODUCTION
TABLE 17 ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 CONTAMINATION TESTING
7.2.1 NEED TO MEET REGULATORY MANDATES FOR CONTAMINATION AND QUALITY TESTING IS A KEY FACTOR DRIVING MARKET GROWTH
TABLE 18 ATP ASSAYS MARKET FOR CONTAMINATION TESTING, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 DISEASE TESTING
7.3.1 GROWING DISEASE INCIDENCE AND RISING AWARENESS ARE EXPECTED TO SUPPORT MARKET GROWTH DURING THE FORECAST PERIOD
TABLE 19 ATP ASSAYS MARKET FOR DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 DRUG DISCOVERY & DEVELOPMENT
7.4.1 INCREASING R&D PIPELINE FOR PHARMACEUTICAL DRUGS WILL DRIVE MARKET GROWTH
TABLE 20 ATP ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
8 ATP ASSAYS MARKET, BY END USER (Page No. – 87)
8.1 INTRODUCTION
TABLE 21 ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST & FASTEST-GROWING END USERS OF ATP ASSAYS
TABLE 22 ATP ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 FOOD & BEVERAGE INDUSTRY
8.3.1 RISING INCIDENCE OF FOOD CONTAMINATION TO DRIVE THE ADOPTION OF ATP ASSAYS
TABLE 23 ATP ASSAYS MARKET FOR FOOD & BEVERAGE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 HOSPITALS & DIAGNOSTIC LABORATORIES
8.4.1 GROWING DEMAND FOR EARLY DISEASE DIAGNOSIS IS A MAJOR FACTOR DRIVING THE ADOPTION OF ATP ASSAYS
TABLE 24 ATP ASSAYS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.5 ACADEMIC & RESEARCH INSTITUTES
8.5.1 ATP ASSAYS ARE USED FOR RESEARCH ACTIVITIES RELATED TO THE GROWTH RATE & VIABILITY OF MICROORGANISMS
TABLE 25 ATP ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
9 ATP ASSAYS MARKET, BY REGION (Page No. – 94)
9.1 INTRODUCTION
TABLE 26 ATP ASSAYS MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: ATP ASSAYS MARKET SNAPSHOT
TABLE 27 NORTH AMERICA: ATP ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 28 NORTH AMERICA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 29 NORTH AMERICA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 30 NORTH AMERICA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 31 NORTH AMERICA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 32 NORTH AMERICA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 US dominates the North American ATP assays market
TABLE 33 US: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 34 US: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 35 US: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 36 US: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 37 US: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Government funding programs for life science research to drive market growth
TABLE 38 CANADA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 39 CANADA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 40 CANADA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 41 CANADA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 42 CANADA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
FIGURE 31 EUROPE: PHARMACEUTICAL R&D EXPENDITURE, 2000–2018 (USD BILLION)
TABLE 43 EUROPE: ATP ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 44 EUROPE: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 45 EUROPE: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 46 EUROPE: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 47 EUROPE: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 48 EUROPE: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Demand for ATP assays is driven by the large-scale outsourcing of clinical diagnostic testing by hospitals to commercial service providers
TABLE 49 GERMANY: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 50 GERMANY: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 51 GERMANY: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 52 GERMANY: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 53 GERMANY: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 UK
9.3.2.1 UK has the largest pharmaceutical R&D expenditure in Europe
TABLE 54 UK: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 55 UK: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 56 UK: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 UK: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 58 UK: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Strong agro-food sector and a major focus on biotechnology R&D to drive market growth in France
TABLE 59 FRANCE: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 60 FRANCE: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 61 FRANCE: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 62 FRANCE: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 63 FRANCE: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 High cancer burden to increase the demand for ATP assays in Italy
TABLE 64 ITALY: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 65 ITALY: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 66 ITALY: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 ITALY: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 68 ITALY: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Growth in the personalized medicine sector and clinical diagnostics market to drive the ATP assays market in Spain
TABLE 69 SPAIN: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 70 SPAIN: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 SPAIN: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 SPAIN: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 73 SPAIN: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 74 ROE: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 75 ROE: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 76 ROE: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 ROE: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 78 ROE: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 32 ASIA PACIFIC: ATP ASSAYS MARKET SNAPSHOT
TABLE 79 ASIA PACIFIC: ATP ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 80 ASIA PACIFIC: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 81 ASIA PACIFIC: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 ASIA PACIFIC: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 83 ASIA PACIFIC: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 84 ASIA PACIFIC: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Increasing pharmaceutical R&D investments in the country to support market growth
TABLE 85 CHINA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 86 CHINA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 CHINA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 CHINA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 89 CHINA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 High incidence of cancer to increase the demand for ATP assays in Japan
TABLE 90 JAPAN: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 91 JAPAN: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 JAPAN: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 JAPAN: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 94 JAPAN: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Growing adoption of ATP assay techniques in research and clinical applications to drive the market in India
TABLE 95 INDIA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 96 INDIA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 INDIA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 INDIA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 99 INDIA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 REST OF APAC
TABLE 100 ROAPAC: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 101 ROAPAC: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 ROAPAC: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 ROAPAC: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 104 ROAPAC: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
TABLE 105 LATIN AMERICA: ATP ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 106 LATIN AMERICA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 107 LATIN AMERICA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 108 LATIN AMERICA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 LATIN AMERICA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 110 LATIN AMERICA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Increasing research activities & expanding pharmaceutical market in Brazil is fueling the market for ATP assays
TABLE 111 BRAZIL: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 112 BRAZIL: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 BRAZIL: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 114 BRAZIL: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 115 BRAZIL: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Increase in research centers and manufacturing to drive the demand for ATP assays in Mexico
TABLE 116 MEXICO: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 117 MEXICO: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 MEXICO: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 119 MEXICO: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 120 MEXICO: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 121 ROLATAM: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 122 ROLATAM: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 ROLATAM: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 124 ROLATAM: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 125 ROLATAM: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 GROWING FUNDING INITIATIVES AND STRATEGIC PARTNERSHIPS IS DRIVING MARKET GROWTH IN THE MEA
TABLE 126 MEA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 127 MEA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 128 MEA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 MEA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 130 MEA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. – 148)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE ATP ASSAYS MARKET
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 33 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE ATP ASSAYS MARKET
10.4 MARKET RANKING ANALYSIS
FIGURE 34 ATP ASSAYS MARKET RANKING, BY KEY PLAYER, 2021
10.5 COMPETITIVE LEADERSHIP MAPPING
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 35 ATP ASSAYS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES
10.6.3 STARTING BLOCKS
10.6.4 RESPONSIVE COMPANIES
FIGURE 36 ATP ASSAYS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS (2021)
10.7 COMPANY FOOTPRINT
TABLE 131 COMPANY FOOTPRINT: ATP ASSAYS MARKET (2021)
10.7.1 PRODUCT FOOTPRINT OF MAJOR PLAYERS IN THE ATP ASSAYS MARKET
TABLE 132 PRODUCT FOOTPRINT: ATP ASSAYS MARKET (2021)
10.7.2 APPLICATION FOOTPRINT OF MAJOR PLAYERS IN THE ATP ASSAYS MARKET
TABLE 133 APPLICATION FOOTPRINT: ATP ASSAYS MARKET (2021)
10.7.3 END-USER FOOTPRINT OF MAJOR PLAYERS IN THE ATP ASSAYS MARKET
TABLE 134 END-USER FOOTPRINT: ATP ASSAYS MARKET (2021)
10.7.4 GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN THE ATP ASSAYS MARKET
TABLE 135 GEOGRAPHIC FOOTPRINT: ATP ASSAYS MARKET (2021)
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 136 PRODUCT LAUNCHES, JANUARY 2018–FEBRUARY 2022
10.8.2 DEALS
TABLE 137 DEALS, JANUARY 2018–FEBRUARY 2022
10.8.3 OTHER DEVELOPMENTS
11 COMPANY PROFILES (Page No. – 165)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 THERMO FISHER SCIENTIFIC, INC.
TABLE 139 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 37 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
11.1.2 PROMEGA CORPORATION
TABLE 140 PROMEGA CORPORATION: BUSINESS OVERVIEW
11.1.3 MERCK KGAA
FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2021)
11.1.4 NEOGEN CORPORATION
TABLE 142 NEOGEN CORPORATION: BUSINESS OVERVIEW
FIGURE 39 NEOGEN CORPORATION: COMPANY SNAPSHOT (2021)
11.1.5 PERKINELMER, INC.
FIGURE 40 PERKINELMER, INC.: COMPANY SNAPSHOT (2021)
11.1.6 AGILENT TECHNOLOGIES, INC.
FIGURE 41 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2021)
11.1.7 PROMOCELL GMBH
11.1.8 DANAHER CORPORATION
FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
11.1.9 LONZA GROUP
TABLE 147 LONZA GROUP: BUSINESS OVERVIEW
FIGURE 43 LONZA GROUP: COMPANY SNAPSHOT (2021)
11.1.10 ABCAM PLC
FIGURE 44 ABCAM PLC: COMPANY SNAPSHOT (2021)
11.1.11 3M
FIGURE 45 3M: COMPANY SNAPSHOT (2021)
11.1.12 ABNOVA CORPORATION
FIGURE 46 ABNOVA CORPORATION: COMPANY SNAPSHOT (2020)
11.1.13 GENO TECHNOLOGY, INC.
TABLE 151 GENO TECHNOLOGY, INC.: BUSINESS OVERVIEW
11.1.14 AAT BIOQUEST, INC.
TABLE 152 AAT BIOQUEST, INC.: BUSINESS OVERVIEW
11.1.15 BIOTHEMA AB
11.1.16 BIOTIUM
11.1.17 CREATIVE BIOARRAY
11.1.18 CANVAX BIOTECH S.L.
11.1.19 ELABSCIENCE BIOTECHNOLOGY INC.
11.1.20 MBL INTERNATIONAL CORPORATION
TABLE 158 MBL INTERNATIONAL CORPORATION: BUSINESS OVERVIEW
11.2 OTHER COMPANIES
11.2.1 RUHOF CORPORATION
11.2.2 CHARM SCIENCES
11.2.3 BIO SHIELD TECH, LLC
11.2.4 CAYMAN CHEMICAL
11.2.5 CELL SIGNALING TECHNOLOGY
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX (Page No. – 218)
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
